[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-novo-deal-eucalyptus-acquisition-fda-peptides-three-catalysts-reshaping-hims-hers-in-2026-EN":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":342},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},102234,"Novo Deal, Eucalyptus Acquisition, FDA Peptides: Three Catalysts Reshaping Hims & Hers in 2026","2026-04-21T12:40:00","2026-04-20T08:15:13","\u003Cp>The Novo deal ended the legal risk. The Eucalyptus acquisition opens Australia and Japan. The real question is whether Q1 earnings confirm the pivot.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-hims-amp-hers-stock\">Key Stats for Hims & Hers Stock\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>52-Week Range: \u003C\u002Fstrong>$14 to $70\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Current Price: \u003C\u002Fstrong>$29\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Street Mean Target: \u003C\u002Fstrong>$24\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Street High Target:\u003C\u002Fstrong> $30\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>TIKR Model Target \u003Cem>(Dec. 2030)\u003C\u002Fem>:\u003C\u002Fstrong> $65\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>HIMS stock has fallen nearly 59% from its 52-week high while the TIKR model points to a mid-case target of around $65. Find out whether the data supports the discount or confirms the risk: access institutional-grade valuation tools across 60,000+ stocks on TIKR for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>What Happened?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Hims & Hers Health (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=542604862&tid=700682871&ref=q2enxr\">HIMS\u003C\u002Fa>), a direct-to-consumer telehealth platform selling personalized treatments across sexual health, dermatology, weight loss, and an expanding range of new specialties, sits at $29 as the market reprices what Hims & Hers Health stock is actually worth after the collapse of cheap compounded GLP-1 drug margins.\u003C\u002Fp>\n\n\n\n\u003Cp>The company’s defining moment in 2026 came on March 9, when \u003Ca href=\"https:\u002F\u002Fwww.reuters.com\u002Flegal\u002Flitigation\u002Fnovo-nordisk-strikes-deal-hims-sell-wegovy-ozempic-drops-lawsuit-2026-03-09\u002F\">Novo Nordisk struck a deal with Hims to distribute branded Wegovy and Ozempic injections and pills through its platform at self-pay prices starting at $149 per month\u003C\u002Fa>, ending a patent lawsuit that had threatened both the company’s growth strategy and its regulatory standing.\u003C\u002Fp>\n\n\n\n\u003Cp>The transition carries a real cost: \u003Ca href=\"https:\u002F\u002Ffinance.yahoo.com\u002Fsectors\u002Fhealthcare\u002Farticles\u002Fhims-hers-price-target-slashed-162500261.html\">BofA cut its price target to $21 from $23 in early April\u003C\u002Fa>, estimating GLP-1 EBITDA contribution could fall around 50% year over year as the company shifts from high-margin compounded products to lower-margin branded ones, projecting roughly $60 million to $90 million in quarterly GLP-1 revenue from the new arrangement.\u003C\u002Fp>\n\n\n\n\u003Cp>Andrew Dudum, Co-Founder and CEO, stated on the \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ftranscript?cid=542604862&tid=700682871&e=1982097543&ts=3661010&ref=q2enxr\">Q4 2025 earnings call\u003C\u002Fa> that “before ever scaling our weight loss offering, we built a platform that surpassed $1 billion in revenue and achieved profitability by scaling offerings like sexual health and dermatology, specialties that continue to grow today with strong unit economics that allow us to fund the next opportunities for growth.”\u003C\u002Fp>\n\n\n\n\u003Cp>The 2030 roadmap anchors the bull case: a \u003Ca href=\"https:\u002F\u002Fwww.reuters.com\u002Flegal\u002Flitigation\u002Fhims-hers-health-acquire-australias-eucalyptus-up-115-billion-2026-02-19\u002F\">$1.15 billion acquisition of Eucalyptus (closing mid-2026) adds Australia and Japan exposure\u003C\u002Fa>, the international business targets more than $1 billion in annual revenue within three years, and an \u003Ca href=\"https:\u002F\u002Fwww.reuters.com\u002Fbusiness\u002Fhealthcare-pharmaceuticals\u002Fhims-rises-fda-considers-broader-peptides-access-analysts-see-long-term-win-2026-04-16\u002F\">FDA expert panel review of 12 peptides announced April 16 could unlock a new revenue stream using the company’s existing California peptide facility \u003C\u002Fa>— three catalysts that have nothing to do with the GLP-1 transition that drove Hims & Hers Health stock down from $70.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>The Novo Nordisk deal, the Eucalyptus acquisition, and the FDA peptide review are all moving fast: track how analyst price targets shift as each catalyst develops on TIKR for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-wall-street-s-take-on-hims-stock\">\u003Cstrong>Wall Street’s Take on HIMS Stock\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The GLP-1 transition has convinced most of Wall Street to stand down: the near-term EBITDA hit is real, and consensus is not yet willing to look through it to what the platform becomes on the other side.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"681\" data-public-id=\"images\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_681,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA\" alt=\"hims & hers stock revenue & ebitda estimates\" class=\"wp-post-102234 wp-image-102245\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1776672792\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_681,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_798,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_931,c_scale\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1776672792\u002Fimages\u002Fimage-576_102245bfa6e\u002Fimage-576_102245bfa6e.png?_i=AA 1492w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">HIMS Stock Revenue & EBITDA Estimates \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Festimates?cid=542604862&tid=700682871&tab=est&ref=q2enxr\">(TIKR)\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>HIMS generated $2.35 billion in revenue in 2025, growing 59% year over year, but consensus now projects growth decelerating sharply to around 16% in 2026, with EBITDA of around $330 million, essentially flat against the $318 million reported in 2025, as the margin drag from the branded GLP-1 transition and international investment absorbs most of the operating leverage the platform would otherwise generate.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"830\" height=\"564\" data-public-id=\"images\u002Fimage-575_102242acedc\u002Fimage-575_102242acedc.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_830,h_564,c_scale\u002Ff_webp,q_auto\u002Fv1776672147\u002Fimages\u002Fimage-575_102242acedc\u002Fimage-575_102242acedc.png?_i=AA\" alt=\"hims & hers stock street analysts target\" class=\"wp-post-102234 wp-image-102242\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1776672147\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1776672147\u002Fimages\u002Fimage-575_102242acedc\u002Fimage-575_102242acedc.png?_i=AA 830w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_204,c_scale\u002Ff_webp,q_auto\u002Fv1776672147\u002Fimages\u002Fimage-575_102242acedc\u002Fimage-575_102242acedc.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_522,c_scale\u002Ff_webp,q_auto\u002Fv1776672147\u002Fimages\u002Fimage-575_102242acedc\u002Fimage-575_102242acedc.png?_i=AA 768w\" sizes=\"auto, (max-width: 830px) 100vw, 830px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Street Analysts Target for HIMS Stock \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>(TIKR)\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Of 16 analysts covering Hims & Hers Health stock, 1 rates it a buy, 2 outperform, and 12 hold, with a mean price target of $24, implying the consensus view is that the stock at $29 is already priced ahead of what the transition period warrants.\u003C\u002Fp>\n\n\n\n\u003Cp>The spread between the $16 bear target and $30 bull target tells the story: the low end prices in prolonged margin compression with limited recovery, while the high end reflects a scenario where the platform’s non-GLP-1 specialties carry the business through the transition intact.\u003C\u002Fp>\n\n\n\n\u003Cp>Priced at roughly 26x forward EBITDA against a business that delivered 80% EBITDA growth in 2025, Hims & Hers Health stock appears undervalued relative to its platform’s demonstrated compounding history, with the Street treating a one-year transition headwind as a structural repricing rather than a temporary recalibration.\u003C\u002Fp>\n\n\n\n\u003Cp>The FDA’s April 16 announcement that it will convene an expert panel to consider loosening restrictions on 12 peptides, including BPC-157 for wound healing and TB-500 for ulcerative colitis applications, is the signal the market has not fully priced: Leerink analyst Michael Cherny noted it “would allow the company to leverage its existing peptide facility,” potentially repurposing GLP-1 capacity toward new revenue streams at the exact moment the compounded weight-loss opportunity is contracting.\u003C\u002Fp>\n\n\n\n\u003Cp>If the Novo deal’s branded GLP-1 subscriber conversion comes in at the low end of BofA’s 40% to 50% retention estimate, near-term free cash flow takes an additional hit the current consensus model has not absorbed.\u003C\u002Fp>\n\n\n\n\u003Cp>Q1 2026 earnings on May 11 are the first real data point: watch whether GLP-1 subscriber attrition tracks at the bottom or top of management’s guided range, and whether new specialties (testosterone, menopause, Labs) are scaling fast enough to offset the revenue headwind.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-does-the-valuation-model-say\">\u003Cstrong>What Does the Valuation Model Say?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The TIKR model assigns HIMS a mid-case price target of around $65, built on a revenue CAGR of around 11% from 2025 through 2030 and a net income margin expanding to around 11%, assumptions that track the company’s stated 2030 target of $6.5 billion in revenue and $1.3 billion in EBITDA rather than what consensus currently prices.\u003C\u002Fp>\n\n\n\n\u003Cp>At $29, with the mid-case implying around 127% upside and an annualized IRR of around 19%, the gap between where the stock trades and where the model lands makes \u003Cstrong>Hims & Hers Health stock deeply undervalued\u003C\u002Fstrong> if the platform’s non-GLP-1 diversification holds through the transition year.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA\" alt=\"hims & hers stock valuation model results\" class=\"wp-post-102234 wp-image-102244\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1776672248\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1776672248\u002Fimages\u002FHIMS_valuation_model_1022443e082\u002FHIMS_valuation_model_1022443e082.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">HIMS Stock Valuation Model Results \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=21127&tid=2621295&ref=tikrblog\">\u003Cstrong>(TIKR)\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>The central question is whether HIMS is a platform business temporarily burdened by a GLP-1 transition, or a GLP-1 business that happens to have other products attached to it.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>What Has to Go Right\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Non-GLP-1 specialties (sexual health, dermatology, hair loss) must sustain their majority share of 2026 revenue, consistent with management’s claim that these drove profitability before GLP-1s were ever part of the mix\u003C\u002Fli>\n\n\n\n\u003Cli>Testosterone, menopause support, and Labs each need to approach a $100 million annual revenue run rate within roughly 12 to 18 months, the timeline Dudum cited on the Q4 call as the near-term expectation for each\u003C\u002Fli>\n\n\n\n\u003Cli>Eucalyptus must close mid-2026, add at least $200 million in second-half revenue as guided, and put the collective international business on a path to breakeven within 12 to 18 months per CFO Yemi Okupe’s stated timeline\u003C\u002Fli>\n\n\n\n\u003Cli>The FDA peptide panel must produce a favorable recommendation, allowing HIMS to monetize its existing California facility and repurpose GLP-1 manufacturing capacity toward new, higher-margin personalized treatments\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>What Could Go Wrong\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>BofA estimates GLP-1 EBITDA contribution falls around 50% year over year even under a favorable branded conversion; if subscriber churn runs above the 40% to 50% retention estimate, the shortfall hits both revenue and margins simultaneously\u003C\u002Fli>\n\n\n\n\u003Cli>The 2026 EBITDA guidance midpoint of around $338 million is essentially flat to 2025 actuals, and BofA’s own forecast sits roughly 20% below Wall Street consensus, suggesting the Street has not fully modeled the transition drag\u003C\u002Fli>\n\n\n\n\u003Cli>International markets (ZAVA, Livewell, Eucalyptus) are all guided to run near breakeven, meaning margin expansion is almost entirely dependent on domestic specialty scaling at a pace that new launches have not yet confirmed\u003C\u002Fli>\n\n\n\n\u003Cli>A data breach disclosed April 2 affecting a third-party customer service platform introduces reputational risk at the exact moment HIMS needs subscriber trust to execute conversions from compounded to branded GLP-1 treatments\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>The HIMS thesis hinges on whether the platform’s non-GLP-1 engine is big enough to carry growth through 2026: catch Q1 earnings data and any analyst revisions the moment they hit on TIKR for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-hims-amp-hers-health-inc\">\u003Cstrong>Should You Invest in Hims & Hers Health, Inc.?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.\u003C\u002Fp>\n\n\n\n\u003Cp>Pull up HIMS stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.\u003C\u002Fp>\n\n\n\n\u003Cp>You can build a free watchlist to track Hims & Hers Health, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Access Professional Tools to Analyze HIMS stock on TIKR for Free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",1407,"en","\u002Fblog\u002Fnovo-deal-eucalyptus-acquisition-fda-peptides-three-catalysts-reshaping-hims-hers-in-2026","novo-deal-eucalyptus-acquisition-fda-peptides-three-catalysts-reshaping-hims-hers-in-2026","images\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776672879\u002Fimages\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed\u002FFEATURED-IMAGE-MAKER-361_1022461b4ed.png?_i=AA",{"altText":237,"imageCredit":238},"Novo Deal, Eucalyptus Acquisition, FDA Peptides: Three Catalysts Reshaping Hims & Hers in 2026","TIKR",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Gian Estrada","giantikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"David Hanson","davidtikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Stock Reviews","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"The Novo deal ended the legal risk. The Eucalyptus acquisition opens Australia and Japan. The real question is whether Q1 earnings confirm the pivot.",{"title":225,"description":258,"twitterTitle":225,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":225,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Est. reading time","8 minutes",1200,630,[266,281,296,310,327],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"Humana Stock Could Return 250% if the Medicare Advantage Recovery Delivers","2026-04-21 12:40:00","CMS finalized a 5% Medicare payment boost. Now Humana faces Q1 earnings on April 29, and the benefit ratio tells the whole story.",1472,"\u002Fblog\u002Fhumana-stock-could-return-250-if-the-medicare-advantage-recovery-delivers","humana-stock-could-return-250-if-the-medicare-advantage-recovery-delivers","images\u002FFEATURED-IMAGE-MAKER-360_102231b06f7\u002FFEATURED-IMAGE-MAKER-360_102231b06f7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776666014\u002Fimages\u002FFEATURED-IMAGE-MAKER-360_102231b06f7\u002FFEATURED-IMAGE-MAKER-360_102231b06f7.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":293,"relatedPosts":295},"From $145 to $244 in a Year: Can Marathon Petroleum Stock Sustain Its Refining Advantage?","2026-04-21 12:30:00","Marathon Petroleum trades at 10x forward earnings on a year when EPS is expected to nearly double. Something doesn't add up.",1578,"\u002Fblog\u002Ffrom-145-to-244-in-a-year-can-marathon-petroleum-stock-sustain-its-refining-advantage","from-145-to-244-in-a-year-can-marathon-petroleum-stock-sustain-its-refining-advantage","images\u002FFEATURED-IMAGE-MAKER-358_102214df16b\u002FFEATURED-IMAGE-MAKER-358_102214df16b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776663396\u002Fimages\u002FFEATURED-IMAGE-MAKER-358_102214df16b\u002FFEATURED-IMAGE-MAKER-358_102214df16b.png?_i=AA",{"altText":282},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":292},[],[294],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":297,"date":283,"excerpt":298,"wordCount":299,"uri":300,"slug":301,"cloudinaryAssetId":302,"featuredImageOriginalUrl":303,"featuredImageMetadata":304,"author":305,"categories":307,"relatedPosts":309},"Merck Spends $6.7 Billion on a CML Drug: What the Terns Deal Means for MRK Investors in 2026","Merck spent $6.7 billion on a CML drug with multibillion-dollar potential. The April 30 call reveals if the core business is tracking.",1340,"\u002Fblog\u002Fmerck-spends-6-7-billion-on-a-cml-drug-what-the-terns-deal-means-for-mrk-investors-in-2026","merck-spends-6-7-billion-on-a-cml-drug-what-the-terns-deal-means-for-mrk-investors-in-2026","images\u002FFEATURED-IMAGE-MAKER-359_1022224415d\u002FFEATURED-IMAGE-MAKER-359_1022224415d","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776664726\u002Fimages\u002FFEATURED-IMAGE-MAKER-359_1022224415d\u002FFEATURED-IMAGE-MAKER-359_1022224415d.png?_i=AA",{"altText":297},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":306},[],[308],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":311,"date":312,"excerpt":313,"wordCount":314,"uri":315,"slug":316,"cloudinaryAssetId":317,"featuredImageOriginalUrl":318,"featuredImageMetadata":319,"author":320,"categories":324,"relatedPosts":326},"EverCommerce Rose 6% This Week. Here’s How Much the Stock Could Rise in 2026","2026-04-21 12:05:00","EverCommerce stock rose about 6% this week as investors leaned into a stabilizing growth story driven by improving profitability, AI adoption, and stronger recurring revenue trends. Here’s why the company’s shift toward higher-margin software and payments could support upside into 2026.",648,"\u002Fblog\u002Fevercommerce-rose-6-this-week-heres-how-much-the-stock-could-rise-in-2026","evercommerce-rose-6-this-week-heres-how-much-the-stock-could-rise-in-2026","images\u002F@Eugen-Tamass-Images-via-Canva\u002F@Eugen-Tamass-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776759501\u002Fimages\u002F@Eugen-Tamass-Images-via-Canva\u002F@Eugen-Tamass-Images-via-Canva.png?_i=AA",{"altText":311},{"name":321,"slug":322,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":323},"Nikko Henson","nikkotikr",[],[325],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":328,"date":329,"excerpt":330,"wordCount":331,"uri":332,"slug":333,"cloudinaryAssetId":334,"featuredImageOriginalUrl":335,"featuredImageMetadata":336,"author":337,"categories":339,"relatedPosts":341},"Record $4.2 Billion Cash Flow and Colgate-Palmolive Stock Still Trades at a Discount","2026-04-21 12:00:00","Hill's grew 60% in five years. AI is doubling conversion rates. Now Colgate-Palmolive stock needs North America to catch up.",1455,"\u002Fblog\u002Frecord-4-2-billion-cash-flow-and-colgate-palmolive-stock-still-trades-at-a-discount","record-4-2-billion-cash-flow-and-colgate-palmolive-stock-still-trades-at-a-discount","images\u002FFEATURED-IMAGE-MAKER-357_10220874101\u002FFEATURED-IMAGE-MAKER-357_10220874101","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776662636\u002Fimages\u002FFEATURED-IMAGE-MAKER-357_10220874101\u002FFEATURED-IMAGE-MAKER-357_10220874101.png?_i=AA",{"altText":328},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":338},[],[340],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[343,362,377,392,406,423,442,460,475,490,505,520,535,550,565],{"id":255,"title":344,"date":283,"excerpt":345,"wordCount":346,"uri":347,"slug":348,"cloudinaryAssetId":349,"featuredImageOriginalUrl":350,"featuredImageMetadata":351,"author":352,"categories":356,"relatedPosts":361},"Tim Cook Is Stepping Down as Apple CEO. Here's Why the Stock Still Has Upside in 2026","Apple just confirmed one of the most consequential leadership changes in corporate history: Tim Cook is stepping down as CEO. For investors sitting at $273, the real question is whether the transition is a reason to buy, hold, or worry. ",1267,"\u002Fblog\u002Ftim-cook-is-stepping-down-as-apple-ceo-heres-why-the-stock-still-has-upside-in-2026","tim-cook-is-stepping-down-as-apple-ceo-heres-why-the-stock-still-has-upside-in-2026","images\u002F5-4_1023140116e\u002F5-4_1023140116e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736983\u002Fimages\u002F5-4_1023140116e\u002F5-4_1023140116e.png?_i=AA",{"altText":344},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":355},"Wiltone Asuncion","wiltonetikr",[],[357],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},"General Investing","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":363,"date":364,"excerpt":365,"wordCount":366,"uri":367,"slug":368,"cloudinaryAssetId":369,"featuredImageOriginalUrl":370,"featuredImageMetadata":371,"author":372,"categories":374,"relatedPosts":376},"JPMorgan Stock Falls After Q1 2026 Earnings Beat: What a $338 Street Target Means for Investors","2026-04-21 12:20:00","JPMorgan posted record trading revenue and beat Q1 2026 earnings estimates, yet the stock fell on a net interest income guidance cut. Jamie Dimon warned the next credit cycle could be worse than investors expect. Here's what the numbers say. ",1105,"\u002Fblog\u002Fjpmorgan-stock-falls-after-q1-2026-earnings-beat-what-a-338-street-target-means-for-investors","jpmorgan-stock-falls-after-q1-2026-earnings-beat-what-a-338-street-target-means-for-investors","images\u002F4-4_10231354c69\u002F4-4_10231354c69","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736975\u002Fimages\u002F4-4_10231354c69\u002F4-4_10231354c69.png?_i=AA",{"altText":363},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":373},[],[375],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":378,"date":379,"excerpt":380,"wordCount":381,"uri":382,"slug":383,"cloudinaryAssetId":384,"featuredImageOriginalUrl":385,"featuredImageMetadata":386,"author":387,"categories":389,"relatedPosts":391},"NVIDIA Stock Is Up 18% in 10 Days. Is the Six-Month Consolidation Finally Over?","2026-04-21 12:10:00","NVIDIA stock has broken out of a six-month trading range, surging 18% in 10 days to reclaim $200 for the first time since its October all-time high. Investors are asking whether this is finally the real move. Here's what the data says.",1374,"\u002Fblog\u002Fnvidia-stock-is-up-18-in-10-days-is-the-six-month-consolidation-finally-over","nvidia-stock-is-up-18-in-10-days-is-the-six-month-consolidation-finally-over","images\u002F3-4_10231249633\u002F3-4_10231249633","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736971\u002Fimages\u002F3-4_10231249633\u002F3-4_10231249633.png?_i=AA",{"altText":378},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":388},[],[390],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":393,"date":329,"excerpt":394,"wordCount":395,"uri":396,"slug":397,"cloudinaryAssetId":398,"featuredImageOriginalUrl":399,"featuredImageMetadata":400,"author":401,"categories":403,"relatedPosts":405},"Tesla Has Lost 20% in 2026. Could Q1 Earnings Be the Turning Point?","Tesla stock has fallen 20% in 2026, caught between a struggling car business and a market that still prices it like a trillion-dollar AI platform. With Q1 2026 earnings dropping April 22, the question isn't whether results will be messy; it's whether the Cybercab era can finally justify the multiple.",1243,"\u002Fblog\u002Ftesla-has-lost-20-in-2026-could-q1-earnings-be-the-turning-point","tesla-has-lost-20-in-2026-could-q1-earnings-be-the-turning-point","images\u002F2-4_1023110124b\u002F2-4_1023110124b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776736960\u002Fimages\u002F2-4_1023110124b\u002F2-4_1023110124b.png?_i=AA",{"altText":393},{"name":353,"slug":354,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":402},[],[404],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":407,"date":408,"excerpt":409,"wordCount":410,"uri":411,"slug":412,"cloudinaryAssetId":413,"featuredImageOriginalUrl":414,"featuredImageMetadata":415,"author":416,"categories":420,"relatedPosts":422},"Melius Research Raises Dell Stock Price Target Amid Surging Server Demand","2026-04-21 11:09:00","Melius Research raises Dell stock price target to $200, citing surging AI server demand and faster-than-expected enterprise AI adoption.",636,"\u002Fblog\u002Fmelius-research-raises-dell-nyse-stock-price-target-amid-surging-server-demand","melius-research-raises-dell-nyse-stock-price-target-amid-surging-server-demand","images\u002FDELL-stock_10240667100\u002FDELL-stock_10240667100","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776754391\u002Fimages\u002FDELL-stock_10240667100\u002FDELL-stock_10240667100.png?_i=AA",{"altText":407},{"name":417,"slug":418,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":419},"Aditya Raghunath","adityatikr",[],[421],{"name":358,"slug":359,"uri":360,"description":243,"postsCount":255},[],{"id":255,"title":424,"date":425,"excerpt":243,"wordCount":426,"uri":427,"slug":428,"cloudinaryAssetId":429,"featuredImageOriginalUrl":430,"featuredImageMetadata":431,"author":432,"categories":436,"relatedPosts":441},"Jeffrey Gendell: From a 91.5% Drawdown to a 100-Bagger","2026-04-21 12:01:34",521,"\u002Fblog\u002Fjeffrey-gendell","jeffrey-gendell","images\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1776772825\u002Fimages\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return\u002FTIKR.com_IES-Holdings-Inc.-IESC-Total-Return.png?_i=AA",{"altText":424},{"name":433,"slug":434,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":435},"Sahil Khetpal","sahil",[],[437],{"name":438,"slug":439,"uri":440,"description":243,"postsCount":255},"Top Investors","top-investors","\u002Fblog\u002Fcategory\u002Ftop-investors",[],{"id":255,"title":443,"date":444,"excerpt":445,"wordCount":446,"uri":447,"slug":448,"cloudinaryAssetId":449,"featuredImageOriginalUrl":450,"featuredImageMetadata":451,"author":452,"categories":454,"relatedPosts":459},"Zillow Group Stock Hits Full-Year GAAP Profitability as Rentals Accelerates","2026-04-20 19:40:00","Zillow hit GAAP profitability and guided $700M for Q1 2026. The question is how much of the thesis needs housing to recover.",1262,"\u002Fblog\u002Fzillow-group-stock-hits-full-year-gaap-profitability-as-rentals-accelerates","zillow-group-stock-hits-full-year-gaap-profitability-as-rentals-accelerates","images\u002FFEATURED-IMAGE-MAKER-356_1022025f673\u002FFEATURED-IMAGE-MAKER-356_1022025f673","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776661880\u002Fimages\u002FFEATURED-IMAGE-MAKER-356_1022025f673\u002FFEATURED-IMAGE-MAKER-356_1022025f673.png?_i=AA",{"altText":443},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":453},[],[455],{"name":456,"slug":457,"uri":458,"description":243,"postsCount":255},"Earnings Updates","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":255,"title":461,"date":462,"excerpt":463,"wordCount":464,"uri":465,"slug":466,"cloudinaryAssetId":467,"featuredImageOriginalUrl":468,"featuredImageMetadata":469,"author":470,"categories":472,"relatedPosts":474},"CBRE Group Posts Record Q4 Revenue and Core EPS in Strong 2025 Finish","2026-04-20 19:20:00","CBRE posted record Q4 revenue and 18% EPS growth, but the real debate is whether data center momentum holds into 2026.",1190,"\u002Fblog\u002Fcbre-group-posts-record-q4-revenue-and-core-eps-in-strong-2025-finish","cbre-group-posts-record-q4-revenue-and-core-eps-in-strong-2025-finish","images\u002FFEATURED-IMAGE-MAKER-355_1021947a26b\u002FFEATURED-IMAGE-MAKER-355_1021947a26b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776660491\u002Fimages\u002FFEATURED-IMAGE-MAKER-355_1021947a26b\u002FFEATURED-IMAGE-MAKER-355_1021947a26b.png?_i=AA",{"altText":461},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":471},[],[473],{"name":456,"slug":457,"uri":458,"description":243,"postsCount":255},[],{"id":255,"title":476,"date":477,"excerpt":478,"wordCount":479,"uri":480,"slug":481,"cloudinaryAssetId":482,"featuredImageOriginalUrl":483,"featuredImageMetadata":484,"author":485,"categories":487,"relatedPosts":489},"Astera Labs Revenue More Than Doubled in 2025. Is the Stock Still Cheap?","2026-04-20 19:00:00","Astera Labs more than doubled revenue in 2025. But with opex accelerating and the biggest product ramp still ahead, the debate is just beginning.",1254,"\u002Fblog\u002Fastera-labs-revenue-more-than-doubled-in-2025-is-the-stock-still-cheap","astera-labs-revenue-more-than-doubled-in-2025-is-the-stock-still-cheap","images\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776656657\u002Fimages\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed\u002FFEATURED-IMAGE-MAKER-354_102186ab4ed.png?_i=AA",{"altText":476},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":486},[],[488],{"name":456,"slug":457,"uri":458,"description":243,"postsCount":255},[],{"id":255,"title":491,"date":492,"excerpt":493,"wordCount":494,"uri":495,"slug":496,"cloudinaryAssetId":497,"featuredImageOriginalUrl":498,"featuredImageMetadata":499,"author":500,"categories":502,"relatedPosts":504},"Ventas Stock Delivers Fourth Straight Year of Double-Digit SHOP NOI Growth","2026-04-20 17:40:00","Four straight years of double-digit SHOP NOI growth. Baby boomers just started turning 80. Ventas stock is at 86% occupancy with room to run.",1285,"\u002Fblog\u002Fventas-stock-delivers-fourth-straight-year-of-double-digit-shop-noi-growth","ventas-stock-delivers-fourth-straight-year-of-double-digit-shop-noi-growth","images\u002FFEATURED-IMAGE-MAKER-350_10208352e4b\u002FFEATURED-IMAGE-MAKER-350_10208352e4b","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776580220\u002Fimages\u002FFEATURED-IMAGE-MAKER-350_10208352e4b\u002FFEATURED-IMAGE-MAKER-350_10208352e4b.png?_i=AA",{"altText":491},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":501},[],[503],{"name":456,"slug":457,"uri":458,"description":243,"postsCount":255},[],{"id":255,"title":506,"date":507,"excerpt":508,"wordCount":509,"uri":510,"slug":511,"cloudinaryAssetId":512,"featuredImageOriginalUrl":513,"featuredImageMetadata":514,"author":515,"categories":517,"relatedPosts":519},"Corteva Stock Hits Record 22% EBITDA Margin as Licensing Strategy Accelerates","2026-04-20 15:50:00","Corteva crossed 22% EBITDA margins for the first time. Now a $610 million Bayer settlement is pulling the licensing ramp years forward.",1217,"\u002Fblog\u002Fcorteva-stock-hits-record-22-ebitda-margin-as-licensing-strategy-accelerates","corteva-stock-hits-record-22-ebitda-margin-as-licensing-strategy-accelerates","images\u002FFEATURED-IMAGE-MAKER-349_102079121fb\u002FFEATURED-IMAGE-MAKER-349_102079121fb","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776574989\u002Fimages\u002FFEATURED-IMAGE-MAKER-349_102079121fb\u002FFEATURED-IMAGE-MAKER-349_102079121fb.png?_i=AA",{"altText":506},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":516},[],[518],{"name":456,"slug":457,"uri":458,"description":243,"postsCount":255},[],{"id":255,"title":521,"date":522,"excerpt":523,"wordCount":479,"uri":524,"slug":525,"cloudinaryAssetId":526,"featuredImageOriginalUrl":527,"featuredImageMetadata":528,"author":529,"categories":531,"relatedPosts":534},"Block Raises 2026 AOI Guidance to $3.2 Billion After Strongest NVA Year on Record","2026-04-20 16:00:00","Block raised its 2026 AOI guide to $3.2 billion, up 54%. Nearly 60% of that number is riding on the second half.","\u002Fblog\u002Fblock-raises-2026-aoi-guidance-to-3-2-billion-after-strongest-nva-year-on-record","block-raises-2026-aoi-guidance-to-3-2-billion-after-strongest-nva-year-on-record","images\u002FFEATURED-IMAGE-MAKER-342_102031506a3\u002FFEATURED-IMAGE-MAKER-342_102031506a3","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776522160\u002Fimages\u002FFEATURED-IMAGE-MAKER-342_102031506a3\u002FFEATURED-IMAGE-MAKER-342_102031506a3.png?_i=AA",{"altText":521},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":530},[],[532],{"name":76,"slug":75,"uri":533,"description":243,"postsCount":255},"\u002Fblog\u002Fcategory\u002Ffundamental-analysis",[],{"id":255,"title":536,"date":537,"excerpt":538,"wordCount":539,"uri":540,"slug":541,"cloudinaryAssetId":542,"featuredImageOriginalUrl":543,"featuredImageMetadata":544,"author":545,"categories":547,"relatedPosts":549},"Amer Sports Stock Delivers 27% Revenue Growth as Salomon Crosses $2 Billion in Sales","2026-04-19 12:40:00","Amer Sports grew 27% in 2025 with three brand engines firing. The question is whether the margin investment in Salomon is temporary or structural.",1247,"\u002Fblog\u002Famer-sports-stock-delivers-27-revenue-growth-as-salomon-crosses-2-billion-in-sales","amer-sports-stock-delivers-27-revenue-growth-as-salomon-crosses-2-billion-in-sales","images\u002FFEATURED-IMAGE-MAKER-347_102065dfae9\u002FFEATURED-IMAGE-MAKER-347_102065dfae9","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776566743\u002Fimages\u002FFEATURED-IMAGE-MAKER-347_102065dfae9\u002FFEATURED-IMAGE-MAKER-347_102065dfae9.png?_i=AA",{"altText":536},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":546},[],[548],{"name":76,"slug":75,"uri":533,"description":243,"postsCount":255},[],{"id":255,"title":551,"date":552,"excerpt":553,"wordCount":554,"uri":555,"slug":556,"cloudinaryAssetId":557,"featuredImageOriginalUrl":558,"featuredImageMetadata":559,"author":560,"categories":562,"relatedPosts":564},"Helios Technologies Q4 2025: EPS Up 145%, Dividend Raised for the First Time Ever","2026-04-18 15:00:00","Helios Technologies returned to revenue growth for the first time in three years. Whether the momentum holds through 2026 is a harder question.",1307,"\u002Fblog\u002Fhelios-technologies-q4-2025-eps-up-145-dividend-raised-for-the-first-time-ever","helios-technologies-q4-2025-eps-up-145-dividend-raised-for-the-first-time-ever","images\u002FFEATURED-IMAGE-MAKER-341_101995d387e\u002FFEATURED-IMAGE-MAKER-341_101995d387e","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776497160\u002Fimages\u002FFEATURED-IMAGE-MAKER-341_101995d387e\u002FFEATURED-IMAGE-MAKER-341_101995d387e.png?_i=AA",{"altText":551},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":561},[],[563],{"name":76,"slug":75,"uri":533,"description":243,"postsCount":255},[],{"id":255,"title":566,"date":567,"excerpt":568,"wordCount":569,"uri":570,"slug":571,"cloudinaryAssetId":572,"featuredImageOriginalUrl":573,"featuredImageMetadata":574,"author":575,"categories":577,"relatedPosts":579},"Amazon's P\u002FE Ratio: Current Levels, Historical Trends, and Outlook","2026-04-17 12:00:00","Amazon's 10-year average P\u002FE was 105x. Amazon stock now trades at 35x. The earnings era has arrived.",2693,"\u002Fblog\u002Famazon-pe-ratio","amazon-pe-ratio","images\u002FFEATURED-IMAGE-MAKER-327_10179767c52\u002FFEATURED-IMAGE-MAKER-327_10179767c52","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1776394372\u002Fimages\u002FFEATURED-IMAGE-MAKER-327_10179767c52\u002FFEATURED-IMAGE-MAKER-327_10179767c52.png?_i=AA",{"altText":566},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":576},[],[578],{"name":76,"slug":75,"uri":533,"description":243,"postsCount":255},[]]